Articles

10.4244/EIJV9I6A106 Oct 25, 2013
ESC Journals working together
Cummins P, Serruys PW
free

10.4244/EIJV9I6A107 Oct 25, 2013
Radiation - the double-edged sword of interventional procedures
Roguin A
free

10.4244/EIJV9I6A108 Oct 25, 2013
Cognitive performance in patients with resistant hypertension following renal sympathetic denervation
Lambert G, Dhar A, Schlaich M
free

10.4244/EIJV9I6A109 Oct 25, 2013
The European Heart Journal and EuroIntervention: information and education in interventional cardiology
Lüscher T, de Feyter P, Sabaté M, Van Mieghem NM, Mahfoud F, Serruys PW
free

10.4244/EIJV9I6A111 Oct 25, 2013
First-in-man report of a novel dedicated radiofrequency catheter for renal denervation via the transulnar approach
Jiang X-J, Dong H, Liang T, Zou Y-B, Xu B, Gao R
free

10.4244/EIJV9I6A112 Oct 25, 2013
Novel use of NavX three-dimensional mapping to guide renal artery denervation
Zaman S, Pouliopoulos J, Al Raisi S, Sullivan J, Thiagalingam A, Swinnen J, Kovoor P
free

10.4244/EIJV9I6A113 Oct 25, 2013
Percutaneous sympathectomy of the renal arteries: the OneShot™ Renal Denervation System is not associated with significant vessel wall injury
Stabile E, Ambrosini V, Squarcia R, Salemme L, Popusoi G, Esposito G, Trimarco B, Rubino P
free

10.4244/EIJV9I6A114 Oct 25, 2013
Anxiety, depression, quality of life and stress in patients with resistant hypertension before and after catheter-based renal sympathetic denervation
Lenski D, Kindermann I, Lenski M, Ukena C, Bunz M, Mahfoud F, Böhm M
free

10.4244/EIJV9I6A115 Oct 25, 2013
The edge vascular response following implantation of the Absorb everolimus-eluting bioresorbable vascular scaffold and the XIENCE V metallic everolimus-eluting stent. First serial follow-up assessment at six months and two years: insights from the first-in-man ABSORB Cohort B and SPIRIT II trials
Gogas B, Bourantas C, Garcia-Garcia H, Onuma Y, Muramatsu T, Farooq V, Diletti R, van Geuns R, De Bruyne B, Chevalier B, Thuesen L, Smits PC, Dudek D, Koolen J, Windecker S, Whitbourn R, McClean D, Dorange C, Miquel-Hebert K, Veldhof S, Rapoza R, Ormiston J, Serruys PW
free

10.4244/EIJV9I6A116 Oct 25, 2013
Two-year follow-up of the NEVO ResElution-I(NEVO RES-I) trial: a randomised, multicentre comparison of the NEVO sirolimus-eluting coronary stent with the TAXUS Liberté paclitaxel-eluting stent in de novo native coronary artery lesions
Abizaid A, Ormiston J, Fajadet J, Mauri L, Schofer J, Verheye S, Dens J, Thuesen L, Macours N, Qureshi A, Spaulding C
free

10.4244/EIJV9I6A117 Oct 25, 2013
Assessment of self-expanding nitinol stent deformation after chronic implantation into the femoropopliteal arteries
Nikanorov A, Schillinger M, Zhao H, Minar E, Schwartz L
free

10.4244/EIJV9I6A118 Oct 25, 2013
Beta radiation for renal nerve denervation: initial feasibility and safety
Waksman R, Barbash I, Chan R, Randolph P, Makuria A, Virmani R
free

10.4244/EIJV9I6A119 Oct 25, 2013
A review of radiation exposures associated with radial cardiac catheterisation
Park E, Shroff A, Crisco L, Vidovich M
free
Receive our newsletter


The Official Journal of EuroPCR and the European Association of Percutaneous Cardiovascular Interventions (EAPCI)

EuroPCR EAPCI
PCR ESC
Impact factor: 6.2
2022 Journal Citation Reports®
Science Edition (Clarivate Analytics, 2023)
Online ISSN 1969-6213 - Print ISSN 1774-024X
© 2005-2024 Europa Group - All rights reserved